Reference entry
Cardiogen (AEDR)
AEDR · Cardiovascular Bioregulator Peptide
Overview
Cardiogen is a Khavinson bioregulator peptide consisting of four amino acids, derived from heart tissue research. Unlike larger peptides that work on cell surfaces, Cardiogen penetrates directly to the cell nucleus where it binds to specific DNA regions to regulate gene expression. This epigenetic mechanism supports…
Cardiogen works through epigenetic regulation by penetrating cell nuclei and interacting with specific DNA regions, histones, and nucleosomes. It regulates which genes are activated or suppressed without changing DNA sequence. This mechanism supports cardiac tissue repair, myocardial function, and improves…
Supports heart tissue repair through gene expression regulation at the nuclear level.
May improve overall myocardial function and cardiac performance.
Addresses age-related cardiovascular decline through bioregulation.
Mechanism
Cardiogen is a Khavinson bioregulator peptide consisting of four amino acids, derived from heart tissue research. Unlike larger peptides that work on cell surfaces, Cardiogen penetrates directly to the cell nucleus where it binds to specific DNA regions to regulate gene expression. This epigenetic mechanism supports…
Cardiogen works through epigenetic regulation by penetrating cell nuclei and interacting with specific DNA regions, histones, and nucleosomes. It regulates which genes are activated or suppressed without changing DNA sequence. This mechanism supports cardiac tissue repair, myocardial function, and improves…
Supports heart tissue repair through gene expression regulation at the nuclear level.
Research areas
- Cardiogen is a Khavinson bioregulator peptide consisting of four amino acids, derived from heart tissue research. Unlike larger peptides that work on cell surfaces, Cardiogen penetrates directly to the cell nucleus where it binds to specific DNA regions to regulate gene expression. This epigenetic mechanism supports…
- Cardiogen works through epigenetic regulation by penetrating cell nuclei and interacting with specific DNA regions, histones, and nucleosomes. It regulates which genes are activated or suppressed without changing DNA sequence. This mechanism supports cardiac tissue repair, myocardial function, and improves…
- Supports heart tissue repair through gene expression regulation at the nuclear level.
- May improve overall myocardial function and cardiac performance.
- Addresses age-related cardiovascular decline through bioregulation.
Research notes
- Generally well-tolerated
- Minimal side effects reported
- Unusual cardiac symptoms
- Active cardiac emergencies (seek medical care)
- Pregnancy or breastfeeding
Questions
How does Cardiogen improve cardiac function if it's just 4 amino acids?
Cardiogen's short tetrapeptide (AEDR) penetrates directly into cell nuclei where it regulates cardiac gene expression epigenetically. Despite being only 4 amino acids, this structure is sufficient for DNA binding and histonemodulation, allowing it to influence which genes are activated in heart tissue without altering…
Can Cardiogen help after a heart attack or cardiac event?
Cardiogen's mechanism supports post-cardiac event recovery by promoting cardiac tissue repair and myocardial function improvement through gene expression modulation. However, no clinical human data exists on cardiac event recovery. This remains theoretical based on mechanisms and traditional use in Russian medicine.
Is Cardiogen safe for people with existing heart conditions?
Cardiogen is well-tolerated with minimal side effects reported. People with cardiac conditions should consult healthcare providers before use. Active cardiac emergencies require immediate medical care, not peptide therapy. For chronic cardiovascular support, medical supervision is prudent.
How often should I cycle Cardiogen for heart health maintenance?
Standard protocol is 10-20 day cycles repeated 2-3 times yearly for cumulative cardiovascular benefits. Effects persist between cycles due to epigenetic changes. Some users perform cycles seasonally, while others maintain 2-3 yearly cycles consistently for long-term cardiac tissue support and age-related decline…